Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Inflammatory Bowel Disease
100%
Diabetes Mellitus
100%
Disease Pattern
100%
Disease Severity
100%
Immunomodulator
20%
Disease Control
13%
Hospitalization
13%
Diabetes Diagnosis
13%
Natural History
6%
Antibiotic Use
6%
Clinical Follow-up
6%
Hyperglycemia
6%
Healthcare Utilization
6%
Antibiotics
6%
Quality of Life
6%
Narcotics
6%
Ulcerative Colitis
6%
Crohn's Disease
6%
Emergency Room
6%
Highly Effective
6%
Non-associated
6%
Eosinophilia
6%
Monocytosis
6%
Hypoalbuminemia
6%
Clinic Visits
6%
Disease Groups
6%
Erythrocyte Sedimentation Rate
6%
Prevalence of Diabetes Mellitus
6%
Diabetes Mellitus Patients
6%
Biological Agents
6%
5-aminosalicylic Acid (5-ASA)
6%
Gastroenterology
6%
Tertiary Care Centers
6%
High Use
6%
Elevated C-reactive Protein
6%
Antihyperglycemic Treatment
6%
Inflammatory Bowel Disease Questionnaire
6%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Patient with Inflammatory Bowel Disease
100%
Diabetes Mellitus
100%
Diseases
100%
Immunomodulating Agent
21%
Biological Product
14%
Disease Severity
14%
Biological Marker
7%
Quality of Life
7%
Health Care Utilization
7%
Prevalence
7%
Gastroenterology
7%
Ulcerative Colitis
7%
Hyperglycemia
7%
Identified Patient
7%
Eosinophilia
7%
Hypoalbuminemia
7%
C Reactive Protein
7%
Monocytosis
7%
Antibiotics
7%
4-Aminosalicylic Acid
7%
Antimicrobial Agent
7%
Erythrocyte Sedimentation Rate
7%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Immunomodulating Drugs
18%
Biological Product
12%
Prevalence
6%
C-Reactive Protein
6%
Ulcerative Colitis
6%
Antimicrobial Agent
6%
Erythrocyte Sedimentation Rate
6%